Back
Acasti Pharma 10K Form
Buy
51
ACST
Acasti Pharma
Last Price:
2.73
Seasonality Move:
19.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-13 | 10Q | ACST/Acasti Pharma Quarterly |
| 2023-08-11 | 10Q | ACST/Acasti Pharma Quarterly |
| 2023-02-14 | 10Q | ACST/Acasti Pharma Quarterly |
| 2022-11-14 | 10Q | ACST/Acasti Pharma Quarterly |
| 2022-08-11 | 10Q | ACST/Acasti Pharma Quarterly |
| 2022-02-14 | 10Q | ACST/Acasti Pharma Quarterly |
Receive ACST News And Ratings
See the #1 stock for the next 7 days that we like better than ACST
ACST Financial Statistics
Sales & Book Value
| Annual Sales: | $196K |
|---|---|
| Cash Flow: | $-1.89M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.88 |
| Price / Book: | 0.4 |
Profitability
| EPS (TTM): | -4.57780 |
|---|---|
| Net Income (TTM): | $-38.77M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Acasti Pharma Earnings Forecast
Key Acasti Pharma Financial Ratios
- The Selling, General & Administrative Expenses for ACST have been equal to 3,395.41% of Gross Profit Margin.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 14 years have been positive in 7 years.
Acasti Pharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ACST |
| CUSIP: | 00430K |
| Website: | acastipharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ACST Technical Analysis vs Fundamental Analysis
Buy
51
Acasti Pharma (ACST)
is a Buy
Is Acasti Pharma a Buy or a Sell?
-
Acasti Pharma stock is rated a Buy
The current Acasti Pharma [ACST] share price is $2.76. The Score for ACST is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.